Skye Bioscience, Inc. SKYE
1.22 USD -0.10 (-7.58%)
At closeNov 3, 2026, 4:02 PM EST
1.22 0.00 0.00%
After hours · Nov 3, 4:02 PM ET
1.22 Day range 1.35
1.22 52-week range 12.80
- YTD
- -79.67%
- 1 year
- -89.83%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 18.00 +1375.4% upside
Now 1.22
- Target (low)
- 14.00
- Target (mean)
- 18.00
- Target (high)
- 21.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy3
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.285 | -0.34 – -0.25 | 0.00 | 0.0% | 0 | 0.0% | 6 |
| Next quarter | -0.28 | -0.31 – -0.24 | -0.18 | -55.6% | 0 | 0.0% | 4 |
| Current year | -0.88167 | -1.26 – -0.74 | -5.07 | +82.6% | 0 | 0.0% | 6 |
| Next year | -1.14 | -1.33 – -0.95 | -0.88167 | -29.5% | 0 | 0.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 2024 | Scotiabank | Initiated | — | Sector Outperform |
| Sep 20, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Sep 20, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Sep 10, 2024 | JMP Securities | Initiated | — | Market Outperform |
| Sep 9, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Sep 6, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 27, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jul 9, 2024 | Craig-Hallum | Initiated | — | Buy |
| Jul 1, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 18, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 17, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| May 23, 2024 | Cantor Fitzgerald | Initiated | — | Overweight |
| Apr 12, 2024 | Oppenheimer | Initiated | — | Outperform |
| Mar 14, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 5, 2024 | Piper Sandler | Initiated | — | Overweight |